Impact activated retention feature for drug delivery device
AssigneeAmgen Inc.
InventorsEmil Gram Spork, Matias Melander, Alexandre Gegelashvili, Yangkun Song, Thomas Peter Sonderby
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmgen Inc.
InventorsEmil Gram Spork, Matias Melander, Alexandre Gegelashvili, Yangkun Song, Thomas Peter Sonderby
Estimating the term…
A drug delivery device includes a housing having proximal and distal ends and a longitudinal axis extending therebetween, an injection assembly at least partially disposed within the housing including a needle or a cannula, a drive assembly operably coupled with the injection assembly, a shield slidably coupled with the housing and operably coupled with the drive assembly, and a retention mechanism. The drive assembly is engageable to deliver a medicament via the injection assembly. The shield is positionable in an extended position in which at least a proximal end extends a distance beyond the proximal end of the housing and a retracted position where the proximal end of the housing protrudes a distance beyond the proximal end of the shield. Moving the shield to the retracted position engages the drive assembly to deliver the medicament via the injection assembly. The retention mechanism limits movement of the drive assembly to restrict engagement thereof such that the drive assembly is restricted from delivering the medicament via the injection assembly.
A drug delivery device comprising:
A drug delivery device comprising:
Dependencies are inferred from the claim text.